Evidence map›Paper›PMID 25881078›Full record

ArticleBMC health services research2015

Predictors of chronic cerebrospinal venous insufficiency procedure use among older people with multiple sclerosis: a national case-control study.

Michelle Ploughman, Olivia J Manning, Serge Beaulieu, Chelsea Harris, Stephen H Hogan, Nancy Mayo, John D Fisk, A Dessa Sadovnick, Paul O'Connor, Sarah A Morrow and 7 more

Abstract read
In one paragraph

Article in BMC health services research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Michelle PloughmanRecovery and Performance Laboratory, Rehabilitation Research Unit, Faculty of Medicine, Memorial University, Rm 400, L.A. Miller Centre, 100 Forest Rd, St. John's, NL, Canada. mploughm@mun.ca.
Olivia J ManningRecovery and Performance Laboratory, Rehabilitation Research Unit, Faculty of Medicine, Memorial University, Rm 400, L.A. Miller Centre, 100 Forest Rd, St. John's, NL, Canada. ojm632@mun.ca.
Serge BeaulieuEastern Health Authority, St. John's, NL, Canada. serge.beaulieu@easternhealth.ca.
Chelsea HarrisRecovery and Performance Laboratory, Rehabilitation Research Unit, Faculty of Medicine, Memorial University, Rm 400, L.A. Miller Centre, 100 Forest Rd, St. John's, NL, Canada. Chelsea.harris@mun.ca.
Stephen H HoganRecovery and Performance Laboratory, Rehabilitation Research Unit, Faculty of Medicine, Memorial University, Rm 400, L.A. Miller Centre, 100 Forest Rd, St. John's, NL, Canada. stevehogan@novaphysio.ca.
Nancy MayoClinical Epidemiology, McGill University, Montreal, QC, Canada. nancy.mayo@mcgill.ca.
John D FiskDepartment of Psychiatry, Faculty of Medicine, Dalhousie University, Halifax, NS, Canada. john.fisk@cdha.nshealth.ca.
A Dessa SadovnickDepartment of Medical Genetics and Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, BC, Canada. dessa.sadovnick@gmail.com.
Paul O'ConnorDepartment of Neurology, St. Michaels Regional Hospital, Toronto, ON, Canada. oconnorp@smh.ca.
Sarah A MorrowLondon Health Science Centre, London, ON, Canada. smorrow@uwo.ca.
Luanne M MetzClinical Neurosciences, University of Calgary, Calgary, AB, Canada. Luanne.metz@albertahealthservices.ca.
Penelope SmythDepartment of Neurology, University of Alberta, Edmonton, AB, Canada. penelopesmyth@med.ualberta.ca.
Penelope W AllderdiceRecovery and Performance Laboratory, Rehabilitation Research Unit, Faculty of Medicine, Memorial University, Rm 400, L.A. Miller Centre, 100 Forest Rd, St. John's, NL, Canada. allderdice.pw@gmail.com.
Susan ScottClinical Epidemiology, McGill University, Montreal, QC, Canada. Susan.scott@clinepi.mcgill.ca.
Ruth Ann MarrieDepartments of Internal Medicine and Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada. rmarrie@exchange.hsc.mb.ca.
Mark StefanelliDepartment of Neurology, Faculty of Medicine, Memorial University, St. John's, NL, Canada. mstephane@mun.ca.
Marshall GodwinPrimary Health Care Research Unit, Faculty of Medicine, Memorial University, St. John's, NL, Canada. godwinm@mun.ca.

Funding

Canadian Institutes of Health Research
6 · The paper itself

Abstract

backgroundFollowing the initial reports of Chronic Cerebrospinal Venous Insufficiency (CCSVI) and the purported curative potential of venoplasty, (coined the 'liberation' procedure) Canadians living with multiple sclerosis (MS) began to travel abroad to receive the unregulated procedure, often placing them at odds with their health providers. The purpose of this study was to determine the factors influencing older MS patients' decision to undergo the procedure in order to develop more specific and targeted health information.

methodsWe performed secondary analysis of data collected as part of the 'Canadian Survey of Health Lifestyle and Aging with MS' from people over the age of 55 years with MS symptoms for 20 or more years. The survey consisted of self-reported information on impairments, disability, participation, demographics, personal and environmental factors. In order to compare respondents who underwent the procedure to those who did not and to develop a predictive model, we created a comparison group using a case-control algorithm, controlling for age, gender and education, and matching procedure cases to controls 1:3. We used multivariate stepwise least likelihood regression of 'a priori' variables to determine predictive factors.

resultsThe prevalence of the 'liberation' procedure in our sample was 12.8% (95/743), substantially lower than reported in previous studies of complementary/alternative treatments in MS. The predictive model contained five factors; living alone (Odds ratio 0.24, 95%CI 0.09-0.63), diagnosis of anxiety (Odds ratio 0.29, 95%CI 0.10 - 0.84), rating of neurologist's helpfulness (Odds ratio 0.56, 95%CI 0.44 -0 .71), Body Mass Index (Odds ratio 0.93, 95%CI, 0.89 - 0.98) and perceived physical impact of MS (Odds ratio 1.02, 95%CI 1.01 - 1.04).

conclusionsPredictive factors differed from previous studies of complementary/alternative treatment use likely due to both the invasiveness of the procedure and the advanced age of our study cohort. Our findings suggest that health professionals should target information on the risks and benefits of unregulated procedures to those patients who feel dissatisfied with their neurologist and they should include family members in discussions since they may be providing the logistical support to travel abroad and undergo the 'liberation' procedure. Our findings may be applicable to others with chronic disabling conditions who contemplate the user-pay unregulated invasive procedures available to them.

Indexed as

Multiple SclerosisAgedAged, 80 and overBrainCanadaCase-Control StudiesChronic DiseaseCross-Sectional StudiesFemaleForecastingHumansMaleMiddle AgedOdds RatioPrevalenceSpinal Cord

Identifiers

PMID25881078
PMCPMC4424567

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.